date,title,source
Oct-29-18,"Galmed Pharmaceuticals to Report Third Quarter 2018 Financial Results and Provide Business Update on Monday, November 5",PR Newswire
Oct-31-18,"Nantahala Capital Managements Returns, AUM, and Holdings",Insider Monkey
Nov-05-18,"Galmed Pharmaceuticals (GLMD) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-05-18,Galmed Pharmaceuticals: 3Q Earnings Snapshot,Associated Press
Nov-05-18,Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-14-18,"Recent Analysis Shows COUPA SOFTWARE, Galmed Pharmaceuticals, Sunworks, Murphy, Diversicare Healthcare Services, and Pro-Dex Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Nov-20-18,Galmed Pharmaceuticals (GLMD) in Focus: Stock Moves 6.2% Higher,Zacks
Dec-11-18,Novan Announces Top-Line Data From Mid-Stage Molluscum Study,Zacks
Dec-12-18,What does Galmed Pharmaceuticals Ltd.s (NASDAQ:GLMD) Balance Sheet Tell Us About Its Future?,Simply Wall St.
Dec-28-18,Intercept (ICPT) Benefits from Ocaliva's Recovery in 2018,Zacks
Mar-06-19,"Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2018 Financial Results and Provide Business Update on Wednesday, March 13",PR Newswire
Mar-12-19,Update: Galmed Pharmaceuticals (NASDAQ:GLMD) Stock Gained 95% In The Last Three Years,Simply Wall St.
Mar-12-19,Galmed Reports Positive Results From Pharmacokinetic Split Dose Study of Aramchol,PR Newswire
Mar-13-19,"Galmed Pharmaceuticals (GLMD) Reports Q4 Loss, Misses Revenue Estimates",Zacks
Mar-13-19,Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update,PR Newswire
Apr-09-19,Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start of Phase 3,PR Newswire
